Invest in PatientVR?

For the first time, we are opening up investment opportunities in PatientVR to accelerate our global expansion and drive the future of digital healthcare innovation. With strong industry backing, successful trials, and an expanding market for immersive health technologies, PatientVR presents a compelling opportunity for investors looking to be part of a ground-breaking shift in patient care. The demand for non-pharmaceutical pain management, mental well-being solutions, and digital health tools is rising, and PatientVR is strategically positioned to lead this evolution.

By investing in PatientVR, you’ll be supporting a cutting-edge solution developed by an experienced Australian technology company, Mobiddiction, with a track record of delivering large-scale digital platforms for Government and Enterprise. Join us in making a real impact in healthcare through immersive technology. If you’re interested in exploring investment opportunities, get in touch today.

PatientVR is redefining patient well-being through immersive, interactive virtual reality experiences. Designed with care and precision, PatientVR provides a positive distraction and therapeutic engagement for patients undergoing treatment, recovery, or palliative care. Built with insights from over 300 industry consultations and successfully trialled within leading Australian healthcare institutions, PatientVR is a proven innovation in digital health. With a controller-free design and carefully crafted interactive environments, our solution enhances comfort and reduces stress for patients across diverse healthcare settings.

Mobiddiction has spent over two years developing and refining PatientVR, with extensive research, industry collaboration, and over 300 expert consultations. The platform has undergone successful trials within leading healthcare institutions, including NSW Health and QLD Metro South Health Departments, as well as Nepean Hospital Palliative Care and Logan Hospital. PatientVR has also been showcased internationally as part of the Investment NSW Going Global program, highlighting its potential for global expansion. With a strong foundation in innovation, security, and patient-centric design, PatientVR is ready for commercialisation and broader adoption.

Read about our trials in NSW Health and QLD Metro South Health.

PatientVR is just the beginning. Our vision is to extend the benefits of immersive VR beyond hospital settings and into aged care, home-based healthcare, and community health programs. We aim to provide tailored experiences that support elderly individuals, chronic pain management at home, and mental health therapy in accessible, engaging ways. With international expansion on the horizon, we are also focused on developing region-specific content to ensure cultural relevance and greater patient engagement across global markets.

With continued research, partnerships, and investment, we plan to scale PatientVR into a comprehensive digital health ecosystem that supports patients and healthcare providers across diverse care environments.

• VR is revolutionising patient care by offering non-pharmaceutical pain management solutions, reducing reliance on medication.
• Immersive experiences help lower anxiety, stress, and discomfort, improving overall patient outcomes.
• Hospitals and healthcare providers are increasingly adopting VR for therapy, rehabilitation, and patient education.
• Virtual reality has been proven to enhance engagement and compliance in mental health treatments and cognitive therapies.
• The growth of digital health technology and telemedicine is creating new opportunities for scalable and cost-effective VR solutions.

Read more about how VR is shaping healthcare in recent media coverage.

PatientVR has been featured in various media outlets, highlighting its innovation and impact on healthcare. Read some of our latest media mentions below:

• Investment NSW
• Health Innovation East Midlands
• NSW Health
• Queensland Metro South Health
• SBS Australia

For more press coverage and media stories, visit our news section.